HR Execs on the Move

Alexion Pharmaceuticals

www.alexion.com

 
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Our shared purpose to serve patients in need drives us to find answers, change the world, and create a legacy. Alexion`s three highly innovative therapies treat patients with four severe and ultra-rare diseases, and we are committed to developing additional therapies that have the potential to transform patients` lives. Today, Alexion is advancing the most robust rare disease pipeline in the biotech industry, which, in addition to our complement and metabolic clinical programs, includes more than 30 diverse preclinical programs across ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.alexion.com
  • 100 College Street
    New Haven, CT USA 06510
  • Phone: 203.271.8198

Executives

Name Title Contact Details
Will Hall
Associate Director, HCP Marketing, MeTA , HPP Profile
Annie Powell
Associate Director, Sales Operations and Profile
Laura Sargent
Director, US HCP Marketing Strategy, PNH Profile
Deborah Howe
Director, Global Patient Recruitment and Engagement Profile
Marat Yumagulov
Director Sales Training Development Profile

Similar Companies

Go Partners Heath Care Solutions

Go Partners Heath Care Solutions is a Jefferson City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Checkerspot

Checkerspot is a design-centric materials company enabling ultra-high performance consumer products.

Applied Genomics

Applied Genomics is a Huntsville, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Endocyte Inc

Endocyte Inc is a West Lafayette, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

ImmunoPrecise Antibodies

IPA is a progressive, scientific Contract Research Organization (CRO) recently ranked by one of the pharmaceutical industry`s most trusted, independent market research sources with the highest competitive score, for its antibody service portfolio.1 The company represents a HUB of biotherapeutic intelligence that includes a hybrid of experts and technologies, in the science and business of bioplatform-based discovery. We provide highly specialized full-continuum therapeutic antibody discovery, development, and out-licensing services [Talem] —with advanced omics and complex intelligence technology [LENSai] that provide greater efficiency and accuracy than ever before. Our mission is to provide our pharmaceutical customers with a HUB of the most advanced intelligence and technology to treat disease, bar none. Our goal — is to improve the specificity of biotherapeutics by unlocking the language of the genome.